A Study to Evaluate the Effect of Mild and Moderate Hepatic Impairment on the Single-Dose Pharmacokinetics of Rilzabrutinib (PRN1008)
Clinical trial NCT06444204 · COMPLETED
Trial details
- NCT number
- NCT06444204
- Sponsor
- Principia Biopharma, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-02
- Primary completion
- 2021-03-23
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.